Testing a device that measures melanoma thickness from photos
Part of Cancer, Skin clinical trials.
This trial tests a new device (Dermalyser) that estimates how thick a suspected melanoma is by analyzing a dermoscopy image. It may help doctors plan surgery without needing extra procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a suspicious spot on your skin that might be melanoma, and surgery is already planned to remove it.
- The spot is between 2 and 20 millimeters wide (about the size of a pencil tip to a large pea).
- The spot is not on your genitals, palms, soles, mouth, nose, or eyes, and not on scarred or injured skin.
- You do not have very dark skin (Fitzpatrick skin type V or VI).
- The spot has not been tattooed, marked with a pen, or covered with hair that can't be moved.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two systems that take pictures of your whole skin to find melanoma early. You might qualify if you have a higher risk for melanoma, such as having had melanoma before, many moles, or a strong family history.
This research study analyzes blood and tissue samples from melanoma patients to identify biological markers that could help doctors better understand and treat the disease. Researchers will examine archived tissue samples and blood work to develop improved diagnostic tools.
This study looks at diagnostic and prognostic factors in people who have suspicious pigmented skin lesions or melanoma that doctors are evaluating with surgery or tissue sampling. It may help improve how clinicians decide what the lesion is and what to expect over time.
This study tests a new way to monitor people after surgery for early-stage melanoma. If you qualify, it may help your doctors watch for changes sooner or more accurately during follow-up.
This study is testing a handheld device that scans skin lesions to help detect melanoma. If you have a spot that your doctor thinks could be melanoma, this study will see how well the device works compared to standard checks.
This trial studies a way to help trained clinicians evaluate skin spots (melanocytic lesions) using dermoscopy and augmented histology. It may help improve how consistently lesions are assessed, based on using an online digital tool.
Hear when a new Melanoma (Skin Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.